Articles tagged "Mortality"

2020 American Transplant Congress
The Impact of Initial Alpha-Fetoprotein >100 but <1,000 ng/mL and Pre-Transplant alpha-Fetoprotein Reduction on Outcomes after Liver Transplant in Patients with Hepatocellular Carcinoma
M. L. Goldman¹, K. Zhou², J. L. Dodge¹, F. Yao¹, N. Mehta¹
¹Department of Medicine, UCSF, San Francisco, CA, ²Department of Medicine, USC, Los Angeles, CA
*Purpose: Under current UNOS policy, hepatocellular carcinoma (HCC) patients with alpha-fetoprotein (AFP) >1,000 ng/mL are required to show a reduction in AFP to 100 but
2020 American Transplant Congress
Frailty Prior to Hospital Discharge Predicts Mortality after Cirrhosis-Related Admissions
M. Serper¹, S. Tao², P. Garren¹, D. Peyton¹, M. A. Dunn², K. Reddy¹, A. Gougol², A. Duarte-Rojo²
¹University of Pennsylvania, Philadelphia, PA, ²University of Pittsburgh, Pittsburgh, PA
*Purpose: Inpatient frailty assessment and its utility in clinical care is understudied in liver transplant (LT) candidates. Study objectives were to quantify physical frailty among…
2020 American Transplant Congress
The Relationship Between Frailty and Performance Status in Patients with Cirrhosis Awaiting Liver Transplantation
C. Q. Xu¹, F. Yao², Y. Mohamad², R. Wong², D. Kent², S. Seetharaman², Y. Srisengfa², J. C. Lai²
¹Department of Medicine, UCSF, San Francisco, CA, ²Division of Gastroenterology and Hepatology, Department of Medicine, UCSF, San Francisco, CA
*Purpose: Frailty—a multi-dimensional construct that encapsulates physical function, performance status, and nutritional status—has emerged as a critical determinant of mortality in patients with cirrhosis. Currently,…
2020 American Transplant Congress
Long Term Outcomes Following Uncontrolled and Controlled Donation after Cardiac Death Liver Transplantation in the United States
R. A. Choudhury¹, D. Yoeli¹, H. Yaffe¹, H. B. Moore¹, G. Hoeltzel², A. Schulick¹, K. D. Conzen¹, J. J. Pomposelli¹, E. A. Pomfret¹, T. L. Nydam¹
¹Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, ²Thomas Jefferson University Hospital, Philadelphia, PA
*Purpose: Poor short-term outcomes following uncontrolled donation after cardiac death (uDCD) liver transplantation has led to near non-utilization of such donor allografts in the modern…
2020 American Transplant Congress
Comparison of Six-Month Outcomes in Patients Bridged to Heart Transplantation with Percutaneous Temporary Circulatory Support Before and after the UNOS Allocation System Change
J. Nattiv¹, G. S. Liu¹, P. Banankhah¹, J. Sussex¹, P. Genyk¹, J. Li¹, D. Vucicevic², R. S. Chand³, K. Pandya¹, J. Rahman¹, A. M. Wolfson⁴, A. S. Vaidya¹, E. DePasquale¹
¹Keck Hospital of USC, Los Angeles, CA, ²Newark Beth Israel Medical Center, Newark, NJ, ³Harbor UCLA Medical Center, Los Angeles, CA, ⁴University of Arizona Sarver Heart Center, Tucson, AZ
*Purpose: We report the trends in utilization and outcomes of percutaneous temporary circulatory support (TCS) in the forms of Impella or TandemHeart as a bridge…
2020 American Transplant Congress
Survival Benefit of Accepting Kidneys from Older Donation after Cardiac Death Donors
S. Yu, J. Long, Y. Yu, M. Bowring, J. Motter, T. Ishaque, D. Segev, J. Garonzik-Wang, A. Massie
Johns Hopkins, Baltimore, MD
*Purpose: Kidneys from older donation after cardiac death (DCD) donors are less likely to be transplanted due to concerns about inferior post-transplant survival. But candidates…
2020 American Transplant Congress
Center Performance for Liver Retransplantation Candidates is More Heterogeneous Than for Initial Liver Transplantation Recipients
T. Bittermann, P. L. Abt, D. E. Schaubel
University of Pennsylvania, Philadelphia, PA
*Purpose: This study evaluated center performance for wait-list outcomes for adult candidates awaiting liver retransplantation (reLT), and its association with initial liver transplant (iLT) center…
2020 American Transplant Congress
Graft and Patient Survival after A2-Incompatible Living Donor Kidney Transplantation
S. Getsin, P. Chiang, S. Yu, K. Jackson, D. Segev, A. Massie
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: ABO type B and O recipients have increased difficulty identifying a compatible donor for living-donor kidney transplantation (LDKT), and are harder to match in…
2020 American Transplant Congress
Timing of Bariatric Surgery for Obese Liver Transplant Candidates
R. A. Choudhury¹, D. Yoeli², G. Hoeltzel³, H. B. Moore², H. Yaffe², K. R. Dumon⁴, N. N. Williams⁴, P. L. Abt⁵, K. D. Conzen², J. J. Pomposelli², E. A. Pomfret², T. L. Nydam²
¹Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Denver, CO, ²Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, ³Thomas Jefferson University Hospital, Philadelphia, PA, ⁴Department of Surgery, University of Pennsylvania Hospital, Philadelphia, PA, ⁵Department of Surgery- Division of Transplantation Surgery, University of Pennsylvania Hospital, Philadelphia, PA
*Purpose: The timing of bariatric surgery for obese liver transplant candidates remains controversial. Surgery prior to transplant may improves one’s chance of receiving a transplant,…
2020 American Transplant Congress
Different Prognostic Impact of Liver Transplantation According to Liver Disease Etiologies
S. Nagai, T. Kitajima, S. Yeddula, D. Moonka, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud
Henry Ford Hospital, Detroit, MI
*Purpose: Disease specific background is not taken into consideration in the MELD-Na score based liver transplant (LT) allocation system. We hypothesized that optimal timing of…